Clinical Research Certificate Course

Explore the preclinical trial phase, including drug discovery, formulation development, pharmacology, pharmacokinetics and toxicology, to determine safe starting doses before human testing.

Explore phase i clinical trials, the first in humans, focusing on safety, tolerability, pharmacokinetics, pharmacodynamics, with healthy volunteers and dose escalation in phase 1a and 1b.

Phase two clinical trials evaluate a drug's biological effect and safety in a group, using pilot, case-series, or randomized designs to establish preliminary efficacy and assess at a given dose.

Conduct randomized, multicenter phase three trials to assess effectiveness against standard treatment, with sample sizes from 300 to 3000, long duration, and regulatory submission for approval.

Learn about phase four clinical trials, post-marketing pharmacovigilance that assess long-term safety and effectiveness in diverse, large populations after approval. They identify rare adverse effects and support label expansion.

The sponsor manages and funds a clinical trial, ensures protocol adherence and regulatory compliance, oversees quality assurance and regulatory reporting, and coordinates investigators, training, and site selection.

Identify the principal investigator as the main contact and lead researcher who prepares and executes the clinical trial protocol, analyzes results, monitors safety, and oversees grant administration.

Ethics committee, also called the IRB or IEC, reviews research to protect human rights and participant safety. It ensures informed consent and a favorable risk-benefit ratio under regulatory guidance.

Explore how regulatory agencies shape clinical research, with the FDA in the United States, the EMA in the European Union, and India's CDSCO overseeing research and drug approval.

Explore the main classifications of clinical trial designs, including uncontrolled and controlled trials, randomized and non-randomized allocation, open label and blinded studies, and parallel, crossover, and sequential structures.

Explore ICH GCP, an internationally agreed standard ensuring ethical and scientific quality in human trials, guided by the Declaration of Helsinki, informed consent, and data integrity.

Outlines the clinical trial protocol as a detailed plan covering design, objectives, safety measures, methods, eligibility, data handling, and ethical considerations to protect participants and data integrity.

Explore this sample phase two randomized, double blind, placebo controlled clinical trial protocol evaluating TG 301 intravenously for active ulcerative colitis and outlining objectives, endpoints, eligibility, and investigational plans.

The lecture explains how the informed consent form communicates study purpose, procedures, risks, benefits, confidentiality, compensation, and participants’ rights to potential volunteers, enabling informed participation decisions.

Explore how a sample informed consent form communicates study purpose, two dosing periods, risks, and volunteers' rights in a phase one tafamidis bioequivalence trial.

Explore a sample investigator brochure for Bnt162, outlining safety information, nonclinical studies, pharmacology, ADME, and clinical development for RNA vaccines.

Explore how the case report form (CRF) collects patient data in paper or electronic formats, capturing demographics, adverse events, medical history, and eligibility to test trial hypotheses.

explore how a case report form collects participant data—lab results, medical history, smoking history, oral health, and follow-up vitals—across electronic or physical crf forms to support study objectives.

Congratulations on completing the clinical research certificate course; retrieve your completion certificate, share on LinkedIn, access downloadable materials, and explore pharmacovigilance courses to upgrade your skills and prepare for interviews.